跳至主要内容
临床试验/CTRI/2025/09/095305
CTRI/2025/09/095305尚未招募2 期

Probiotics as an adjunctive therapy in cognitive symptoms of Schizophrenia and its correlation with serum biomarkers and metabolic profile : A double-blind randomized placebo controlled study

Central institute of Psychiatry ,Ranchi1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2025年10月4日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
50
试验地点
1
主要终点
Outcome: Change in cognitive function scores measured by Hindi Montreal Cognitive Assessment (MoCA) from baseline to 4 weeks between probiotic and placebo groups.

研究概览

简要总结

the group 1 (25 patients) receive probiotics and the group 2 (25 patients) receive placebo for 4 weeks .then both groups will be evaluated on PANSS,MOCA, SERUM IL6,BDNF,hsCRP,FBS,BMI,Triglyceride at baseline.this will be repeated with the application of SAFTEE at 2 weeks and 3 weeks

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant, Investigator and Outcome Assessor Blinded

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Participants satisfying the ICD 10-DCR [1993] criteria of schizophrenia
  • 60 years of both sexes.
  • Illness duration of equal to or more than 2 years
  • Patient giving written informed consent.
  • Score between 18 to 25 on screening with Hindi Montreal Cognitive Assessment Test (Hindi MoCA).

排除标准

  • Any other major co-morbid psychiatric diagnosis excluding anxiety disorder, dissociative disorder, adjustment disorders and substance dependence excluding nicotine& caffeine.
  • Presence of any medical,surgical and psychiatric emergency.
  • Any current systemic infection or inflammation or autoimmune disorders, currently using antibiotics, glucocorticoids and other probiotics, known hypersensitivity to probiotics.

结局指标

主要结局

Outcome: Change in cognitive function scores measured by Hindi Montreal Cognitive Assessment (MoCA) from baseline to 4 weeks between probiotic and placebo groups.

时间窗: Time Points: Baseline, 2 weeks, and 4 weeks.

次要结局

  • Change in serum IL-6, hs-CRP, and BDNF levels.

研究者

发起方
Central institute of Psychiatry ,Ranchi
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Dr Shlok nagil

Central Institute of Psychiatry, Ranchi, Kanke, Ranchi, Jharkhand

研究点 (1)

Loading locations...

相似试验